4Life executives recently announced that the company has broken ground on a new manufacturing facility. Construction will take nine or ten months. A ribbon-cutting is scheduled for next year at this time.

The new plant will give 4Life start-to-finish control over every step of the manufacturing process—which will include the batching, blending, encapsulating and packaging of primary 4Life Transfer Factor^© products, including 4Life^© Transfer Factor Plus^© Tri-Factor^© Formula, 4Life Transfer Factor^© Tri-Factor^© Formula, and 4Life Transfer Factor Renuvo^©.

President and CEO Steve Tew: “The facility will adhere to strict current Good Manufacturing Practices as outlined by the Food and Drug Administration and will include state-of- the-art packaging, encapsulation, and blending equipment to ensure the highest level of product quality.”

Raw materials and finished goods will continue to be tested by 4Life scientists in laboratories built for that purpose.

Founder and Chairman of the Board David Lisonbee: “Research remains integral to the products we manufacture. With sixteen years of experience, it makes sense that we control the manufacturing process for our distributors. This is how we guarantee quality and customer satisfaction.”

About 4Life

In 1998, 4Life Founders David and Bianca Lisonbee launched the company’s flagship immune system support product, 4Life Transfer Factor. As the first network marketing company to do so, 4Life’s leading group of doctors, scientists, and researchers continue to advance immune system science with innovations in product formulation, production standards, delivery methods, and more. Today, people in more than 50 countries enjoy the immune system support of 4Life products.